Published: 21 May 2024
Amended: 3 July 2024
Committees
Comments on agenda items for the 72nd meeting of the Medicines Classification Committee to be held on 12 June 2024.
The Medicines Classification Committee and the Secretariat wish to thank everyone for their valuable input and feedback.
A total of three submissions (PDF 542KB, 8 pages) commenting on agenda items for the 72nd meeting were received. Some of the submissions commented on more than one agenda item. Some parts of the comments have been withheld from publication for pursuant to the Official Information Act 1982.
Agenda Item 6.1 Sedating antihistamines
Two comments were received about this agenda item.
Agenda Item 6.2 Respiratory Syncytial Virus vaccine
Two comments were received about this agenda item.
Agenda Item 8.1a Palovarotene
One comment were received about this agenda item.
Agenda Item 8.1b Nirsevimab
One comment was received about this agenda item.
Agenda Item 8.2.1 Bisacodyl
Two comments were received about this agenda item.
Agenda Item 8.2.2 Olopatadine
Two comments were received about this agenda item.
Update
One additional comment (PDF 921KB, 3 pages) was accepted as a late submission. This comment is regarding agenda items: 6.1 Sedating antihistamines, 6.2 Respiratory syncytial virus vaccine, 8.2.1 Bisacodyl, 8.2.2 Olopatadine
